2719. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adults 18–55 Years of Age

BACKGROUND: The MenACYW-TT conjugate vaccine is a quadrivalent meningococcal vaccine that contains tetanus toxoid as carrier protein. The vaccine is intended for global use in all age groups (i.e., individuals 6 weeks of age and older). This Phase III study evaluated the immune lot consistency, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, James, Hedrick, James, Pan, Judy, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810173/
http://dx.doi.org/10.1093/ofid/ofz360.2396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810173/
http://dx.doi.org/10.1093/ofid/ofz360.2396

Ejemplares similares